Physician profile
Ashley Stiegler
NPI 1083676126
$25,261.87
in general payments reported to CMS, 2019-2025
74 companies · $3,831 in 2025
The $3,831 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,742 · 2020: $3,735 · 2021: $4,582 · 2022: $3,571 · 2023: $3,621 · 2024: $3,179 · 2025: $3,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $42.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,588.72 |
| Education | $42.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,064.13 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $1,978.56 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,904.86 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,731.71 | 2019-2025 | Vraylar, Ubrelvy, Synthroid |
| Pfizer INC. | $1,721.81 | 2019-2025 | |
| Lilly USA, LLC | $1,714.71 | 2019-2025 | Jardiance, Mounjaro, Kisunla |
| Amgen INC. | $1,268.43 | 2019-2025 | Otezla, Repatha, Evenity |
| Takeda Pharmaceuticals U.S.A., INC. | $1,227.00 | 2019-2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $976.15 | 2019-2025 | Jardiance, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $798.95 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $780.39 | 2019-2025 | Xifaxan |
| Amarin Pharma, INC. | $577.97 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $509.67 | 2022-2025 | Rexulti |
| Allergan, INC. | $471.20 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $431.17 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $306.10 | 2019-2025 | Veozah |
| Esperion Therapeutics, INC. | $301.46 | 2020-2025 | Nexletol |
| Teva Pharmaceuticals USA, INC. | $287.71 | 2019-2022 | |
| Ibsa Pharma INC. | $271.68 | 2020-2024 | Licart, Tirosint |
| Gilead Sciences, INC. | $254.67 | 2019-2022 | |
| Abbott Laboratories | $249.74 | 2019-2025 | Proclaim, Freestyle Libre 3 |
| Mylan Specialty L.P. | $245.25 | 2022-2024 | Yupelri |
| Corcept Therapeutics | $240.64 | 2025 | Korlym |
| Biohaven Pharmaceutical Holding Company LTD. | $234.03 | 2022 | |
| Exact Sciences Corporation | $223.29 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $213.09 | 2021 | |
| Sanofi-Aventis U.S. LLC | $204.98 | 2019-2022 | |
| Lundbeck LLC | $193.43 | 2023-2024 | Vyepti |
| Shockwave Medical, INC | $192.63 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Supernus Pharmaceuticals, INC. | $173.42 | 2021-2025 | Qelbree, Qelbree |
| Kowa Pharmaceuticals America, INC. | $157.64 | 2021-2025 | Zoryve |
| Axsome Therapeutics, INC. | $154.38 | 2022-2025 | Auvelity |
| Horizon Therapeutics Plc | $145.57 | 2021-2022 | |
| Abiomed | $140.42 | 2022 | |
| Bard Peripheral Vascular, INC. | $122.51 | 2021 | |
| Zoll Respicardia, INC. | $118.18 | 2024 | Remede System |
| Vifor Pharma, INC. | $114.90 | 2021 | |
| Harmony Biosciences LLC | $108.95 | 2020 | |
| Hologic Sales and Service, LLC | $94.82 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Dexcom, INC. | $90.42 | 2024-2025 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $88.52 | 2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $80.47 | 2019-2025 | Spravato |
| Sanofi Pasteur INC. | $71.13 | 2019-2025 | |
| Watermark Medical, INC. | $69.92 | 2020 | |
| Genentech USA, INC. | $69.70 | 2020-2022 | |
| Medtronic, INC. | $61.16 | 2022-2025 | Stealthstation S8 Platform, Inceptiv, Primeadvanced Surescan |
| Arbor Pharmaceuticals, INC. | $60.72 | 2019 | |
| Mannkind Corporation | $59.40 | 2022 | |
| Upsher-Smith Laboratories LLC | $55.39 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $47.92 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $46.50 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $45.07 | 2024 | Voquezna |
| Acadia Pharmaceuticals INC | $40.53 | 2024-2025 | Nuplazid |
| Bausch Health US, LLC | $38.61 | 2022 | |
| Idorsia Pharmaceuticals US INC | $38.10 | 2023 | Quviviq |
| Phadia US INC. | $35.27 | 2022 | |
| Shield Therapeutics INC | $34.21 | 2022-2023 | Accrufer |
| Cranial Technologies, INC | $32.90 | 2023-2025 | Doc Band |
| Avadel Cns Pharmaceuticals, LLC | $32.51 | 2025 | Lumryz |
| Circassia INC. | $26.82 | 2019-2020 | |
| Shire North American Group INC | $25.29 | 2019 | |
| Eisai INC. | $24.48 | 2021 | |
| Corium, LLC | $19.56 | 2025 | Azstarys |
| Inspire Medical Systems, INC. | $19.18 | 2025 | Inspire |
| Tris Pharma INC | $17.16 | 2022 | |
| Nevro Corp. | $17.05 | 2023 | Senza |
| Kaleo, INC. | $16.22 | 2019 | |
| Itamar Medical INC | $15.68 | 2023 | Watchpatone |
| Tolmar, INC. | $15.48 | 2023 | |
| Amneal Pharmaceuticals LLC | $14.08 | 2020 | |
| Nabriva Therapeutics, Plc | $13.66 | 2020 | |
| Stryker Corporation | $12.75 | 2021 | |
| Tms Neurohealth Centers INC. | $12.51 | 2025 | Tms Neurohealth Centers INC. |
| Optos, INC. | $7.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Stiegler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.